AB-506

N/A

Report date: 2025/04/14 16:50:47
NME

Base Information

Drug NameAB-506
Drug Alias NameAB-506
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus capsid protein inhibitors
TargetsHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailandNew ZealandAustralia +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArbutus Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesArbutus Biopharma Corp
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A